** Shares of India's Torrent Pharma TORP.NS jumps 5.4% to 4300 rupees; set for biggest single-day pct gain since July 2025
** Drugmaker posted 26% y/y rise in Q3 net profit to 6.35 billion rupees ($70.04 million), declared a dividend of 29 rupees per share
** Jefferies ("Buy", PT:4690 rupees) says co's December-quarter profit rose broadly in line with estimates, aided by strong India and Brazil performance
** Ambit ("Buy", PT:4150 rupees) says profit was supported by strong branded-market growth, and US launch-led momentum, with margins steady on operating leverage
** Brokerage Antique ("Buy", PT:4610 rupees) attributes the in-line profit to India's outperformance, US launch momentum, and Brazil's strength, driving revenue growth and stable margins
** TORP rated "buy" on average by 27 analysts, PT at 4141 rupees -- data compiled by LSEG
** TORP gained 14.6% in 2025, and the stock jumped ~6% so far in 2026
($1 = 90.6590 Indian rupees)
(Reporting by Surbhi Misra in Bengaluru)
((Surbhi.Misra@thomsonreuters.com | X: https://twitter.com/SurbhiMisra_ |;))